tradingkey.logo

Universal Health Services Inc

UHS

176.990USD

+5.110+2.97%
Handelsschluss 04/30, 16:00ETKurse um 15 Minuten verzögert
11.50BMarktkapitalisierung
10.07KGV TTM

Universal Health Services Inc

176.990

+5.110+2.97%
mehr Informationen über Universal Health Services Inc Unternehmen
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
Unternehmensinformationen
Unternehmens-codeUHS
Name des UnternehmensUniversal Health Services Inc
IPO-datumJul 10, 1981
Gegründet am1979
CEOMr. Marc D. Miller
Anzahl der mitarbeiter86000
WertpapierartOrdinary Share
GeschäftsjahresendeJul 10
Addresse367 S Gulph Rd
StadtKING OF PRUSSIA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl19406
Telefon16107683300
Websitehttps://uhs.com
Unternehmens-codeUHS
IPO-datumJul 10, 1981
Gegründet am1979
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alan B. Miller
Mr. Alan B. Miller
Executive Chairman of the Board
Executive Chairman of the Board
1.90M
+8.46%
Mr. Marc D. Miller
Mr. Marc D. Miller
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
512.02K
+15.64%
Mr. Matthew Jay (Matt) Peterson
Mr. Matthew Jay (Matt) Peterson
Executive Vice President, President of Behavioral Health Division
Executive Vice President, President of Behavioral Health Division
12.76K
+144.51%
Ms. Maria Ruderman Singer
Ms. Maria Ruderman Singer
Independent Director
Independent Director
7.92K
+34.65%
Ms. Eileen C. Mcdonnell
Ms. Eileen C. Mcdonnell
Lead Independent Director
Lead Independent Director
6.41K
--
Dr. Elliot J. Sussman, M.D.
Dr. Elliot J. Sussman, M.D.
Independent Director
Independent Director
5.05K
--
Ms. Nina Chen-Langenmayr
Ms. Nina Chen-Langenmayr
Independent Director
Independent Director
1.99K
--
Mr. Steve G. Filton
Mr. Steve G. Filton
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
--
--
Mr. Edward H. (Eddie) Sim
Mr. Edward H. (Eddie) Sim
Executive Vice President, President - Acute Care Division
Executive Vice President, President - Acute Care Division
--
--
Mr. Warren J. Nimetz
Mr. Warren J. Nimetz
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alan B. Miller
Mr. Alan B. Miller
Executive Chairman of the Board
Executive Chairman of the Board
1.90M
+8.46%
Mr. Marc D. Miller
Mr. Marc D. Miller
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
512.02K
+15.64%
Mr. Matthew Jay (Matt) Peterson
Mr. Matthew Jay (Matt) Peterson
Executive Vice President, President of Behavioral Health Division
Executive Vice President, President of Behavioral Health Division
12.76K
+144.51%
Ms. Maria Ruderman Singer
Ms. Maria Ruderman Singer
Independent Director
Independent Director
7.92K
+34.65%
Ms. Eileen C. Mcdonnell
Ms. Eileen C. Mcdonnell
Lead Independent Director
Lead Independent Director
6.41K
--
Dr. Elliot J. Sussman, M.D.
Dr. Elliot J. Sussman, M.D.
Independent Director
Independent Director
5.05K
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Managed Care
4.50B
28.41%
Managed Medicaid
2.30B
14.56%
Medicaid
2.25B
14.23%
Managed Medicare
1.88B
11.90%
Medicare
1.67B
10.55%
Other
3.22B
20.36%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Managed Care
4.50B
28.41%
Managed Medicaid
2.30B
14.56%
Medicaid
2.25B
14.23%
Managed Medicare
1.88B
11.90%
Medicare
1.67B
10.55%
Other
3.22B
20.36%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
12.17%
First Eagle Investment Management, L.L.C.
8.07%
BlackRock Institutional Trust Company, N.A.
5.68%
State Street Global Advisors (US)
4.67%
Fidelity Management & Research Company LLC
3.40%
Other
66.01%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
12.17%
First Eagle Investment Management, L.L.C.
8.07%
BlackRock Institutional Trust Company, N.A.
5.68%
State Street Global Advisors (US)
4.67%
Fidelity Management & Research Company LLC
3.40%
Other
66.01%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
47.06%
Investment Advisor
31.83%
Hedge Fund
9.17%
Individual Investor
4.72%
Pension Fund
3.15%
Research Firm
1.89%
Bank and Trust
1.26%
Sovereign Wealth Fund
0.85%
Private Equity
0.46%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
1230
58.58M
101.06%
-3.48M
2024Q4
1240
58.31M
100.83%
-4.10M
2024Q3
1178
57.68M
97.04%
-5.31M
2024Q2
1101
58.59M
98.20%
-5.96M
2024Q1
1078
59.75M
99.46%
-5.76M
2023Q4
1052
61.66M
101.08%
-3.98M
2023Q3
1054
61.53M
99.01%
-6.01M
2023Q2
1061
63.26M
100.54%
-4.89M
2023Q1
1057
63.42M
100.97%
-7.50M
2022Q4
1062
66.34M
103.30%
-4.05M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
7.05M
12.17%
-72.04K
-1.01%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
4.68M
8.07%
+44.10K
+0.95%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.29M
5.68%
+25.76K
+0.79%
Dec 31, 2024
State Street Global Advisors (US)
2.70M
4.67%
-19.86K
-0.73%
Dec 31, 2024
Fidelity Management & Research Company LLC
1.97M
3.4%
-475.63K
-19.42%
Dec 31, 2024
Miller (Alan B)
1.90M
3.28%
+148.22K
+8.46%
Mar 21, 2025
Geode Capital Management, L.L.C.
1.71M
2.96%
+52.04K
+3.13%
Dec 31, 2024
Citadel Advisors LLC
1.30M
2.24%
-110.58K
-7.85%
Dec 31, 2024
Arrowstreet Capital, Limited Partnership
1.29M
2.22%
-1.55K
-0.12%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
1.14M
1.97%
-44.29K
-3.74%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
WBI BullBear Value 3000 ETF
3.33%
SPDR S&P Health Care Services ETF
2.25%
First Eagle Global Equity ETF
2.22%
First Trust Health Care Alphadex Fund
2.11%
Alpha Architect US Quantitative Value ETF
1.88%
iShares U.S. Healthcare Providers ETF
1.74%
Invesco S&P 500 Equal Weight Health Care ETF
1.45%
Fidelity Stocks for Inflation ETF
1.32%
WBI BullBear Yield 3000 ETF
1.31%
LeaderShares AlphaFactor US Core ETF
1.3%
Mehr Anzeigen
WBI BullBear Value 3000 ETF
Anteil3.33%
SPDR S&P Health Care Services ETF
Anteil2.25%
First Eagle Global Equity ETF
Anteil2.22%
First Trust Health Care Alphadex Fund
Anteil2.11%
Alpha Architect US Quantitative Value ETF
Anteil1.88%
iShares U.S. Healthcare Providers ETF
Anteil1.74%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.45%
Fidelity Stocks for Inflation ETF
Anteil1.32%
WBI BullBear Yield 3000 ETF
Anteil1.31%
LeaderShares AlphaFactor US Core ETF
Anteil1.3%
Dividende
In den vergangenen 5 Jahren wurden insgesamt 250.51M USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 12, 2025
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Mar 17, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 17, 2025
Mar 03, 2025
Nov 20, 2024
UHS.NB Final Cash Dividend of gross USD 0.2 paid on Dec 17, 2024 going ex on Dec 03, 2024
Dec 03, 2024
Dec 17, 2024
Dec 03, 2024
Jul 18, 2024
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 17, 2024 going ex on Sep 03, 2024
Sep 03, 2024
Sep 17, 2024
Sep 03, 2024
May 15, 2024
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Jan 17, 2024
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 15, 2023
UHS.NB Final Cash Dividend of gross USD 0.2 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Jul 20, 2023
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
May 17, 2023
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Jun 15, 2023 going ex on May 31, 2023
Jun 01, 2023
Jun 15, 2023
May 31, 2023
Jan 18, 2023
UHS.NB Interim Cash Dividend of gross USD 0.2 paid on Mar 15, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 15, 2023
Feb 28, 2023
Nov 16, 2022
UHS.NB Final Cash Dividend of gross USD 0.2 paid on Dec 15, 2022 going ex on Nov 30, 2022
Dec 01, 2022
Dec 15, 2022
Nov 30, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
tradingkey.logo
tradingkey.logo
Intraday-Daten werden von Refinitiv bereitgestellt und unterliegen den Nutzungsbedingungen. Historische und aktuelle End-of-Day-Daten stammen ebenfalls von Refinitiv. Alle Kursangaben entsprechen der lokalen Börsenzeit. Echtzeit-Kursdaten zu US-Aktien beziehen sich ausschließlich auf über Nasdaq gemeldete Transaktionen. Intraday-Daten sind mindestens 15 Minuten oder gemäß den Vorgaben der jeweiligen Börse verzögert.
* Referenzen, Analysen und Handelsstrategien werden vom Drittanbieter Trading Central bereitgestellt, und der Standpunkt basiert auf der unabhängigen Bewertung und Beurteilung des Analysten, ohne die Anlageziele und die finanzielle Situation der Investoren zu berücksichtigen.
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.